Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial – PubMed
ClinicalTrials.gov Identifier: NCT01809691.
Related Articles
‘Operating in the Stone Age’: NHS staff’s daily struggle with outdated tech
Plans to digitise health service must first tackle ‘flip a coin’ nature of equipment across UK, say medical staff
All-in-one gene therapy alternative for DBAS
Diamond-Blackfan anemia syndrome is a ribosomopathy classified among the bone marrow failure syndromes. This disease exhibits significant heterogeneity, with up to 24 genetic variants identified…
Facing death differently: revolutionising our approach to death and grief
Despite growing public interest in death, support for end-of-life care and bereavement remains inadequate. We urgently need a community centred, public health approach to the…
1691P Subcutaneous nivolumab (NIVO SC) vs intravenous nivolumab (NIVO IV) in patients (pts) with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC): Updated efficacy and safety results from CheckMate 67T
CheckMate 67T (NCT04810078) is a multicenter, randomized, open-label, phase 3 trial of NIVO SC vs IV in previously treated pts with advanced/metastatic ccRCC. In the…
Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia
Gene therapy for Diamond-Blackfan anemia is constrained by dozens of causative mutations. Voit and colleagues develop a universal gene therapy through erythroid-lineage-restricted expression of GATA1…
Primary large B-cell lymphomas of immune-privileged sites
Edited by Associate Editor Michael Hallek and Podcast Editor Laurie H. Sehn, this Review Series highlights the biologic features of, clinical phenotype of,
A systematic review of qualitative studies examining barriers and facilitators to orthopaedic surgeon engagement with patient-reported outcome measures data – Journal of Patient-Reported Outcomes
Background Orthopaedic surgeon engagement with patient-reported outcome measures (PROMs) data has not been comprehensively evaluated, despite increasing uptake of orthopaedic PROMs programmes globally. The aim…
Glutamine: The Surprising Link to Prostate Cancer with Dr Jun Gong -EP 128
In this insightful episode of the Dr. Geo Prostate Podcast, Dr. Geo Espinosa sits down with Dr. Jun Gong, a leading medical oncologist at Cedars…
Virtual Meetings | Research To Practice
Research To Practice (RTP) is pleased to offer these complimentary 1-hour CME/MOC-accredited virtual sessions. Each session will be moderated by Dr Neil Love and feature…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
